[When to begin rheumatism treatment? Initial combination therapy helps fastest].
Fath
Roland
R
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016572:Cyclosporine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage*; D000069285:Infliximab; D007555:Isoxazoles / Q000008:administration & dosage*; D000077339:Leflunomide; D008727:Methotrexate / Q000008:administration & dosage*; D011239:Prednisolone / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D012460:Sulfasalazine / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007555:Isoxazoles; D014409:Tumor Necrosis Factor-alpha; D012460:Sulfasalazine; D006886:Hydroxychloroquine; D016572:Cyclosporine; D011239:Prednisolone; D000069285:Infliximab; D000077339:Leflunomide; D008727:Methotrexate